| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022423 |
| Receipt No. | R000025790 |
| Official scientific title of the study | Relation between Sleep-disordered Breathing and Renal Dysfunction in Patients with Acute Coronary Syndrome |
| Date of disclosure of the study information | 2016/05/24 |
| Last modified on | 2016/05/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Relation between Sleep-disordered Breathing and Renal Dysfunction in Patients with Acute Coronary Syndrome | |
| Title of the study (Brief title) | Relation between Sleep-disordered Breathing and Renal Dysfunction in Patients with Acute Coronary Syndrome | |
| Region |
|
|
| Condition | ||
| Condition | acute coronary syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to test the hypothesis that sleep disordered breathing causes the renal dysfunction observed during hospitalization in ACS patients treated with PCI. |
| Basic objectives2 | Others |
| Basic objectives -Others | assessment of complication |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | clinical association between severe sleep disordered breathing and renal dysfunction at discharge |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients admitted with acute coronary syndrome and performed coronary angiography within 24 hours after their admission. | |||
| Key exclusion criteria | died within seven days after admission, chronic kidney disease requiring chronic peritoneal or hemodialysis, chronic heart failure with New York Heart Association Functional Classification>2 | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Masayoshi Kiyokuni |
| Organization | Yokohama City University School of Medicine |
| Division name | Department of Medical Science and Cardiorenal Medicine |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2635 |
| masakiyo@yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Masayoshi Kiyokuni |
| Organization | Yokohama City University School of Medicine |
| Division name | Department of Medical Science and Cardiorenal Medicine |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2635 |
| Homepage URL | |
| masakiyo@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Yokohama City University Medical Center |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Saiseikai Yokohama Southern Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This is prospective observational study. Between May 2011 and March 2014, we recruit consecutive patients with ACS who are admitted to our institute and underwent coronary angiography within 24 hours after admission. Sleep study will be performed for patients estimated glomeular filtration rate on admission and at discharge will be calculated. We examine relationship between sleep disordered breathing and renay dysfunction using these data. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025790 |